ferritin heavy chain Inhibitors

Ferritin Heavy Chain Inhibitors encompass a diverse group of compounds designed to modulate ferritin expression or function. Deferoxamine and Deferasirox are iron-chelating agents that indirectly inhibit ferritin by sequestering iron, preventing its incorporation into ferritin complexes. Apigenin and Quercetin, flavonoids, influence ferritin expression indirectly through the Nrf2/ARE pathway, impacting iron homeostasis. Dp44mT, a thiosemicarbazone compound, indirectly inhibits ferritin by chelating iron and promoting iron-dependent cytotoxicity. 3,4-DHBA, a phenolic compound, modulates ferritin by regulating iron metabolism, affecting ferritin expression and iron storage. DFX (Deferoxamine mesylate) acts similarly to Deferoxamine in inhibiting ferritin by sequestering iron. Ciclopirox, an antifungal agent, possibly influences ferritin expression indirectly through mechanisms related to iron regulation. L-Mimosine, an amino acid derivative, indirectly modulates ferritin by inhibiting iron-dependent enzymes, affecting iron homeostasis. Baicalein, a flavonoid, influences ferritin expression through the Nrf2/ARE pathway, impacting iron homeostasis. Gallium nitrate, a gallium-containing compound, indirectly inhibits ferritin by substituting for iron, disrupting iron homeostasis and storage. DIBI, a small molecule, indirectly modulates ferritin expression, possibly through mechanisms related to iron homeostasis and storage.